EUCTR2009-012039-14-DK进行中（未招募）1 期
Blood- and urinary concentrations of inhaled formoterol in asthmatic subjects and elite asthletes with asthma.
Respiratory and Allergy Research Unit0 个研究点目标入组 30 人开始时间: 2009年5月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •- Physician-diagnosed asthma with positive reversibility test og challenge test.
- •- Informed consent.
- •- Age between 18 - 45 years.
- •- Sex: male.
- •- Asthma classified as mild to moderate according to GINA guidelines.
- •- Used beta-2-agonist in minimum 12 months.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Smokers og ex-smokers with a smoking history of 10 pack years or more.
- •- Respiratory tract infections within the last 2 weeks prior to study day.
- •- Subjects with other chronic diseases than asthma and allergy.
- •- Allergy towards the study medicine.
- •- Use of beta-2-agonist 10 days prior to study day.
研究者
相似试验
进行中（未招募）
1 期
Blood- and urinary concentrations of inhaled salmeterol in asthmatic subjects and elite athletes with asthma.The purpose of this study is to assess the serum and urine concentrations of inhaled salmeterol and evaluate the difference in three groups: healthy men, male asthmatic subjects and male elite athletes with asthma.MedDRA version: 9.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-012069-70-DKBispebjerg Hospital, Respiratory and Allergy Research Unit30
Unknown
4 期
Concentrations of Formoterol in Blood and UrineAsthmaNCT00914654Bispebjerg Hospital30
进行中（未招募）
不适用
Determination of the pharmacokinetics of inhaled mannitol after single and multiple dosing in cystic fibrosis patientsCystic FibrosisEUCTR2008-008228-34-GBPharmaxis Ltd18
已完成
不适用
Study on drug concentration in serum and sputum and clinical effects in patients receiving long-term drug therapy of pulmonary Mycobacterium avium complex disease.Pulmonary Mycobacterium avium complex diseaseJPRN-UMIN000010744aboratory of pharmacotherapeutics, Tokyo University of Science50
进行中（未招募）
1 期
Assessment of meropenem concentrations in lungs in patients with postoperative pneumonia.EUCTR2016-002796-10-ESConsorci Mar Parc de Salut de Barcelona (Parc de Salut MAR)